The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2022 | Highlights from ISTH: gene therapy in hemophilia A & undiagnosed bleeding disorders in pediatrics
Susan Halimeh
• 11 Jul 2022
Susan Halimeh, MD, Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany, share her thoughts on some of the most interesting sessions at ISTH this year, including a talk on gene therapy in hemophilia A and a session on rare undiagnosed bleeding disorders in the pediatric setting. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
